Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 1, 2008, Pages

  Wecht, Jill M ^a,b   Weir, Joseph P ^c   Goldstein, David S ^d   Krothe Petroff, Annmarie ^a   Spungen, Ann M ^a,b   Holmes, Courtney ^d   Bauman, William A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c DES MOINES UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Nitro L arginine methyl ester; Norepinephrine; Spinal cord injury; Sympathetic nervous system

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NORADRENALIN; PLACEBO;

ADRENERGIC SYSTEM; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; ENZYME INHIBITION; HEART RATE; HEMODYNAMICS; HUMAN; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QUADRIPLEGIA; SYMPATHETIC FUNCTION; SYMPATHETIC TONE;

ADULT; BAROREFLEX; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEURAL INHIBITION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; QUADRIPLEGIA; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 38149074632     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00366.2007     Document Type: Article

References (30)

1. Augustyniak RA, Victor RG, Morgan DA, Zhang W. L-NAME- and ADMA-induced sympathetic neural activation in conscious rats. Am J Physiol Regul Integr Comp Physiol 290: R726-R732, 2006.
2. Bleeker MW, Kooijman M, Rongen GA, Hopman MT, Smits P. Preserved contribution of nitric oxide to baseline vascular tone in deconditioned human skeletal muscle. J Physiol 565: 685-694, 2005.
3. Castellano M, Rizzoni D, Beschi M, Muiesan ML, Porteri E, Bettoni G, Salvetti M, Cinelli A, Zulli R, Agabiti-Rosei E. Relationship between sympathetic nervous system activity, baroreflex and cardiovascular effects after acute nitric oxide synthesis inhibition in humans. J Hypertens 13: 1153-1161, 1995.
4. Charkoudian N, Joyner MJ, Barnes SA, Johnson CP, Eisenach JH, Dietz NM, Wallin BG. Relationship between muscle sympathetic nerve activity and systemic hemodynamics during nitric oxide synthase inhibition in humans. Am J Physiol Heart Circ Physiol 291: H1378-H1383, 2006.
5. Christensen NJ, Frankel HL, Mathias CJ, Spalding JM. Proceedings: enhanced pressor response to noradrenaline in human subjects with chronic sympathetic decentralization. J Physiol 252: 39P-40P, 1975.
6. Fekedulegn DB, Andrew ME, Burchfiel CM, Violanti JM, Hartley TA, Charles LE, Miller DB. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom Med 69: 651-659, 2007.
7. Gamboa A, Shibao C, Diedrich A, Choi L, Pohar B, Jordan J, Paranjape S, Farley G, Biaggioni I. Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension 49: 170-177, 2007.
8. Guttmann L, Munro AF, Robinson R, Walsh JJ. Effect of tilting on the cardiovascular responses and plasma catecholamine levels in spinal man. Paraplegia 1: 4-18, 1963.
9. Halliwill JR, Minson CT, Joyner MJ. Effect of systemic nitric oxide synthase inhibition on postexercise hypotension in humans. J Appl Physiol 89: 1830-1836, 2000.
10. Hansen J, Jacobsen TN, Victor RG. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension 24: 439-444, 1994.
11. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 653: 131-138, 1994.
12. Imai Y, Abe K, Munakata M, Sakuma H, Hashimoto J, Imai K, Sekino H, Yoshinaga K. Does ambulatory blood pressure monitoring improve the diagnosis of secondary hypertension? J Hypertens Suppl 8: S71-S75, 1990.
13. Kessler KM, Pina I, Green B, Burnett B, Laighold M, Bilsker M, Palomo AR, Myerburg RJ. Cardiovascular findings in quadriplegic and paraplegic patients and in normal subjects. Am J Cardiol 58: 525-530, 1986.
14. Kooijman M, Rongen GA, Smits P, Hopman MT. Preserved α-adrenergic tone in the leg vascular bed of spinal cord-injured individuals. Circulation 108: 2361-2367, 2003.
15. Lepori M, Sartori C, Duplain H, Nicod P, Scherrer U. Sympathectomy potentiates the vasoconstrictor response to nitric oxide synthase inhibition in humans. Cardiovasc Res 43: 739-743, 1999.
16. G-monomethyl-L-arginine into humans are dose dependent. J Hypertens 16: 519-523, 1998.
17. Mathias CJ, Christensen NJ, Corbett JL, Frankel HL, Goodwin TJ, Peart WS. Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted. Clin Sci Mol Med 49: 291-299, 1975.
18. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 300: 230-235, 1990.
19. Mueller PJ, Foley CM, Hasser EM. Hindlimb unloading alters nitric oxide and autonomic control of resting arterial pressure in conscious rats. Am J Physiol Regul Integr Comp Physiol 289: R140-R147, 2005.
20. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ Res 70: 607-611, 1992.
21. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33: 937-942, 1999.
22. ω-nitro-L-arginine methyl ester. Hypertension 30: 64-70, 1997.
23. Schuman EM, Madison DV. Nitric oxide and synaptic function. Annu Rev Neurosci 17: 153-183, 1994.
24. Takahashi M, Sakaguchi A, Matsukawa K, Komine H, Kawaguchi K, Onari K. Cardiovascular control during voluntary static exercise in humans with tetraplegia. J Appl Physiol 97: 2077-2082, 2004.
25. Thijssen DH, Ellenkamp R, Kooijman M, Pickkers P, Rongen GA, Hopman MT, Smits P. A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury. Arterioscler Thromb Vasc Biol 27: 325-331, 2007.
26. Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 262: 343-347, 1992.
27. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997-1000, 1989.
28. Wecht JM, Weir JP, Krothe AH, Spungen AM, Bauman WA. Normalization of supine blood pressure after nitric oxide synthase inhibition in persons with tetraplegia. J Spinal Cord Med 30: 5-9, 2007.
29. Zhang K, Mayhan WG, Patel KP. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol 273: R864-R872, 1997.
30. Zhao J, Wecht JM, Zhang Y, Wen X, Zeman R, Bauman WA, Cardozo C. iNOS expression in rat aorta is increased after spinal cord transection: a possible cause of orthostatic hypotension in man. Neurosci Lett 415: 210-214, 2007.